It is FDA-indicated for three main uses: Cardiovascular Risk Reduction (In a Specific Group) To reduce the risk of major adverse cardiovascular events such as cardiovascular death, non-fatal heart attack, or non-fatal stroke in adults with established cardiovascular disease who also have obesity or are overweight
Abbasinejad, MD , and the team explain that Mounjaro and Ozempic are both highly effective medications for weight management and blood sugar control, but they work through slightly different mechanisms
Individuals with mild deficiencies or those looking to maintain optimal B12 levels
South African Journal of Animal Science 37: 65-73.Google Scholar CORDUK, M., SARICA, S., CALIKOGLU, E
Find Out If Wegovy is Clinically Suitable Clinician-led medical assessment Personalised dosing and nutrition support Ongoing clinical monitoring throughout treatment Possible Side Effects and Interaction Risks to Watch For Using Wegovy alongside ADHD medication may increase certain overlapping side effects, particularly during the early stages of treatment or after dose adjustments